P63 does not regulate brachyury expression in human chordomas and osteosarcomas.
作者信息
Pillay Nischalan, Amary Fernanda M, Berisha Fitim, Tirabosco Roberto, Flanagan Adrienne M
出版信息
Histopathology. 2011 Nov;59(5):1025-7. doi: 10.1111/j.1365-2559.2011.03973.x. Epub 2011 Oct 18.
Abstract
摘要
相似文献
1
P63 does not regulate brachyury expression in human chordomas and osteosarcomas.P63在人类脊索瘤和骨肉瘤中不调节短尾相关转录因子的表达。
Histopathology. 2011 Nov;59(5):1025-7. doi: 10.1111/j.1365-2559.2011.03973.x. Epub 2011 Oct 18.
2
Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas.Brachyury是脊索发育的关键调节因子，是脊索瘤的一种新型生物标志物。
J Pathol. 2006 Jun;209(2):157-65. doi: 10.1002/path.1969.
3
Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.转录因子 T（brachyury）在散发性脊索瘤发病机制中的作用：一项基于遗传和功能的研究。
J Pathol. 2011 Feb;223(3):327-35. doi: 10.1002/path.2816. Epub 2010 Nov 24.
4
Analysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomas.脊索瘤中纤维母细胞生长因子受体-RAS/RAF/MEK/ERK-ETS2/短尾信号通路的分析
Mod Pathol. 2009 Aug;22(8):996-1005. doi: 10.1038/modpathol.2009.63. Epub 2009 May 1.
5
Brachyury and chordoma: the chondroid-chordoid dilemma resolved?短尾蛋白与脊索瘤：软骨样-脊索样难题得到解决了吗？
J Pathol. 2006 Jun;209(2):143-6. doi: 10.1002/path.1987.
6
T gene isoform expression pattern is significantly different between chordomas and notochords.脊索瘤与脊索中T基因亚型的表达模式存在显著差异。
Biochem Biophys Res Commun. 2015 Nov 13;467(2):261-7. doi: 10.1016/j.bbrc.2015.09.178. Epub 2015 Oct 3.
7
Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma.Brachyury 基因拷贝数增加和 PI3K/Akt 通路的激活：与颅底脊索瘤中致癌性 Brachyury 表达的上调相关。
J Neurosurg. 2018 May;128(5):1428-1437. doi: 10.3171/2016.12.JNS161444. Epub 2017 Jul 28.
8
Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.颅底脊索瘤复发的分子和临床危险因素：2p 染色体获得、brachyury 表达和未接受放疗与患者预后呈负相关。
J Neuropathol Exp Neurol. 2013 Sep;72(9):816-23. doi: 10.1097/NEN.0b013e3182a065d0.
9
Chordoma: Immunohistochemical Analysis of Brachury.脊索瘤：Brachury的免疫组织化学分析
Turk Neurosurg. 2018;28(2):174-178. doi: 10.5137/1019-5149.JTN.18587-16.1.
10
Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis.短尾蛋白、SOX-9和血小板内皮细胞黏附分子，颅底脊索瘤与软骨肉瘤鉴别诊断中的新标志物：基于组织芯片的比较分析
Mod Pathol. 2008 Dec;21(12):1461-9. doi: 10.1038/modpathol.2008.144. Epub 2008 Sep 26.
引用本文的文献
1
miR-219-5p inhibits proliferation and clonogenicity in chordoma cells and is associated with tumor recurrence.微小RNA-219-5p抑制脊索瘤细胞的增殖和克隆形成能力，并与肿瘤复发相关。
Oncol Lett. 2016 Dec;12(6):4568-4576. doi: 10.3892/ol.2016.5222. Epub 2016 Oct 5.
Zotero 插件